
Kadmon Holdings, Inc. KDMN
Country |
|
IPO year |
- |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
169 M |
Market Cap[1] |
$ 1.7 B |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Neurocrine Biosciences
NBIX
|
$ 145.91 | 2.25 % | $ 14.5 B | Nasdaq Global Select Market,SPB | ||
|
Orgenesis
ORGS
|
- | -33.86 % | $ 61.2 M | Nasdaq Capital Market | ||
|
Biogen
BIIB
|
$ 252.25 | 0.62 % | $ 37 B | Nasdaq Global Select Market,SPB | ||
|
Minerva Neurosciences
NERV
|
$ 2.2 | -4.35 % | $ 18.6 M | Nasdaq Global Market | ||
|
Nektar Therapeutics
NKTR
|
$ 37.17 | -0.12 % | $ 627 M | Nasdaq Global Select Market,SPB | ||
|
Nkarta
NKTX
|
$ 1.87 | 4.47 % | $ 138 M | Nasdaq Global Select Market | ||
|
NanoViricides
NNVC
|
$ 1.37 | -2.14 % | $ 27.7 M | NYSE American | ||
|
Codiak BioSciences
CDAK
|
- | -55.98 % | $ 2.15 M | Nasdaq Global Market | ||
|
Nurix Therapeutics
NRIX
|
$ 25.55 | 0.83 % | $ 2.21 B | Nasdaq Global Select Market,SPB | ||
|
Kodiak Sciences
KOD
|
$ 89.5 | 2.13 % | $ 4.76 B | Nasdaq Global Market,SPB | ||
|
Intellia Therapeutics
NTLA
|
$ 11.26 | 0.4 % | $ 1.22 B | Nasdaq Global Market,SPB | ||
|
Novavax
NVAX
|
$ 9.4 | -3.14 % | $ 1.52 B | Nasdaq Global Select Market | ||
|
BioLineRx Ltd.
BLRX
|
$ 2.01 | -1.47 % | $ 4.96 B | Nasdaq Capital Market | ||
|
Bristol-Myers Squibb Company
BMY
|
$ 61.57 | 0.15 % | $ 125 B | NYSE,SPB | ||
|
Novartis AG
NVS
|
$ 153.93 | 1.86 % | $ 298 B | NYSE | ||
|
NextCure
NXTC
|
$ 5.22 | 4.72 % | $ 14.8 M | Nasdaq Global Select Market | ||
|
Ocugen
OCGN
|
$ 0.71 | -4.64 % | $ 222 M | Nasdaq Capital Market | ||
|
Ocular Therapeutix
OCUL
|
$ 6.49 | -0.23 % | $ 1.22 B | Nasdaq Global Select Market | ||
|
Oragenics
OGEN
|
$ 0.4 | -3.86 % | $ 863 K | NYSE American | ||
|
Checkpoint Therapeutics
CKPT
|
- | - | $ 169 M | Nasdaq Capital Market | ||
|
Omeros Corporation
OMER
|
$ 16.27 | -1.81 % | $ 1.03 B | Nasdaq Global Select Market | ||
|
Oncolytics Biotech
ONCY
|
$ 0.47 | -5.91 % | $ 45.1 M | Nasdaq Global Select Market | ||
|
ORIC Pharmaceuticals
ORIC
|
$ 8.99 | -31.74 % | $ 789 M | Nasdaq Global Select Market | ||
|
Oramed Pharmaceuticals
ORMP
|
$ 4.08 | -1.21 % | $ 169 M | Nasdaq Global Select Market | ||
|
Outlook Therapeutics
OTLK
|
$ 0.51 | -1.71 % | $ 17.7 M | Nasdaq Global Select Market | ||
|
Ovid Therapeutics
OVID
|
$ 2.15 | -0.23 % | $ 280 M | Nasdaq Global Select Market | ||
|
Sage Therapeutics
SAGE
|
- | - | $ 527 M | Nasdaq Global Select Market,SPB | ||
|
Taro Pharmaceutical Industries Ltd.
TARO
|
- | - | $ 1.62 B | NYSE | ||
|
Nuvation Bio
NUVB
|
$ 4.5 | -1.53 % | $ 1.54 B | NYSE | ||
|
Puma Biotechnology
PBYI
|
$ 10.85 | -1.54 % | $ 543 M | Nasdaq Global Select Market | ||
|
Processa Pharmaceuticals
PCSA
|
$ 1.76 | -2.76 % | $ 2.3 M | Nasdaq Global Select Market | ||
|
Vaxcyte
PCVX
|
$ 59.95 | -0.79 % | $ 8.16 B | Nasdaq Global Select Market | ||
|
Forma Therapeutics Holdings
FMTX
|
- | - | $ 958 M | Nasdaq Global Market | ||
|
Blueprint Medicines Corporation
BPMC
|
- | - | $ 8.14 B | Nasdaq Global Select Market,SPB | ||
|
Pfizer
PFE
|
$ 29.8 | -0.78 % | $ 169 B | NYSE,SPB | ||
|
Horizon Therapeutics Public Limited Company
HZNP
|
- | - | $ 26.6 B | Nasdaq Global Select Market | ||
|
Pharming Group N.V.
PHAR
|
$ 11.85 | 5.8 % | $ 8.16 B | Nasdaq Global Select Market | ||
|
Phathom Pharmaceuticals
PHAT
|
$ 5.94 | 3.48 % | $ 433 M | Nasdaq Global Select Market,SPB | ||
|
Phio Pharmaceuticals Corp.
PHIO
|
$ 0.87 | 2.04 % | $ 5.21 M | Nasdaq Capital Market | ||
|
Lantern Pharma
LTRN
|
$ 0.6 | -5.34 % | $ 6.54 M | Nasdaq Global Select Market | ||
|
Paratek Pharmaceuticals
PRTK
|
- | - | $ 121 M | Nasdaq Global Market | ||
|
Pliant Therapeutics
PLRX
|
$ 0.85 | -1.64 % | $ 52.2 M | Nasdaq Global Select Market | ||
|
ASLAN Pharmaceuticals Limited
ASLN
|
- | -14.27 % | $ 1.7 M | Nasdaq Global Market | ||
|
Adverum Biotechnologies
ADVM
|
- | - | $ 86.2 M | Nasdaq Global Market | ||
|
Unity Biotechnology
UBX
|
- | -33.41 % | $ 3.37 M | Nasdaq Global Select Market | ||
|
Praxis Precision Medicines
PRAX
|
$ 267.68 | 5.82 % | $ 6.02 B | Nasdaq Global Select Market,SPB | ||
|
PainReform Ltd.
PRFX
|
$ 0.74 | 0.07 % | $ 480 K | Nasdaq Capital Market | ||
|
Prelude Therapeutics Incorporated
PRLD
|
$ 3.69 | 1.65 % | $ 284 M | Nasdaq Global Select Market | ||
|
iTeos Therapeutics
ITOS
|
- | - | $ 411 M | Nasdaq Global Market | ||
|
ProQR Therapeutics N.V.
PRQR
|
$ 1.23 | -4.65 % | $ 130 M | Nasdaq Global Market |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.